Published Oct 25, 2026, 11:30 AM ET · Updated 19 days ago · 2 sources
Astra’s Experimental Stomach Cancer Drug Doubled Survival Time
bloomberg
·
Original Report
AstraZeneca Plc’s experimental stomach cancer drug doubled the time patients survived in a late-stage trial, boosting prospects for a potential new blockbuster.